SCHEMBL6958911

SCHEMBL6958911

O=C1Nc2ccc(C#Cc3cccc(O)c3)cc2C1=Cc1ccc[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 11/20 0.72
PDGFRB P09619 6/20 0.72
KDR P35968 5/20 0.72
FLT1 P17948 3/20 0.72
PDGFRA P16234 2/20 0.72
RET P07949 5/20 0.59
FLT3 P36888 3/20 0.59
ALK Q9UM73 3/20 0.59
TLK2 Q86UE8 5/20 0.58
JAK3 P52333 5/20 0.58
CHEK1 O14757 3/20 0.56
AURKB Q96GD4 3/20 0.55
DAPK3 O43293 2/20 0.55
MAP4K4 O95819 2/20 0.55
NTRK1 P04629 2/20 0.55
LCK P06239 2/20 0.55
CSF1R P07333 2/20 0.55
FGFR1 P11362 2/20 0.55
LTK P29376 2/20 0.55
RPS6KA3 P51812 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6958904 1.00 PDPK1 (0.72) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL6963476 0.91 PDPK1 (0.76) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL6963470 0.91 PDPK1 (0.76) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL6970897 0.89 PDPK1 (0.74) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL6970890 0.89 PDPK1 (0.74) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL19691 0.84 PDPK1 (1.00) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL19692 0.84 PDPK1 (1.00) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL6957025 0.84 PDPK1 (0.76) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL6957030 0.84 PDPK1 (0.76) PDPK1PDGFRBKDRFLT1PDGFRA
SCHEMBL6964291 0.83 PDGFRB (0.74) PDPK1PDGFRBKDRFLT1PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149092-B1 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES HOFFMANN LA ROCHE (CH) 2003-10-29 EP claimed
US-6313310-B1 JUN N-TERMINAL KINASE (JNK) ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS; RHEUMATIC ARTHRITIS AND NEURO-DEGENERATIVE DISEASE TREATMENT HOFFMANN-LA ROCHE INC. 2001-11-06 US claimed
EP-1149092-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP claimed
WO-2000035906-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO claimed
EP-1149092-B1 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6313310-B1 JUN N-TERMINAL KINASE (JNK) ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS; RHEUMATIC ARTHRITIS AND NEURO-DEGENERATIVE DISEASE TREATMENT HOFFMANN-LA ROCHE INC. 2001-11-06 US disclosed
EP-1149092-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
WO-2000035906-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed